Adenosine A2A receptor antagonists in Parkinson's disease: still in the running

被引：16

作者：

Antonini, Angelo ^{[1
]}

Poewe, Werner ^{[2
]}

机构：

[1] IRCCS Hosp San Camillo, Parkinson & Movement Disorders Unit, I-30126 Venice, Italy

[2] Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria

来源：

LANCET NEUROLOGY | 2014年 / 13卷 / 08期

关键词：

ISTRADEFYLLINE; THERAPY;

D O I：

10.1016/S1474-4422(14)70153-X

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

100204 [神经病学];

摘要：

引用

收藏

页码：748 / 749

页数：2

相关论文

共 10 条

[1]

A 5-year prospective assessment of advanced Parkinson disease patients treated with subcutaneous apomorphine infusion or deep brain stimulation [J].

Antonini, Angelo ;

Isaias, Ioannis U. ;

Rodolfi, Giorgia ;

Landi, Andrea ;

Natuzzi, Francesca ;

Siri, Chiara ;

Pezzoli, Gianni .

JOURNAL OF NEUROLOGY, 2011, 258 (04) :579-585

[2]

A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease [J].

Bibbiani, F ;

Oh, JD ;

Petzer, JP ;

Castagnoli, N ;

Chen, JF ;

Schwarzschild, MA ;

Chase, TN .

EXPERIMENTAL NEUROLOGY, 2003, 184 (01) :285-294

[3]

Hauser RA, 2014, LANCET NEUROL

[4]

Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial [J].

Hauser, Robert A. ;

Cantillon, Marc ;

Pourcher, Emmanuelle ;

Micheli, Federico ;

Mok, Vincent ;

Onofrj, Marco ;

Huyck, Susan ;

Wolski, Kenneth .

LANCET NEUROLOGY, 2011, 10 (03) :221-229

[5]

Novel nondopaminergic targets for motor features of Parkinson's disease: Review of recent trials [J].

Kalia, Lorraine V. ;

Brotchie, Jonathan M. ;

Fox, Susan H. .

MOVEMENT DISORDERS, 2013, 28 (02) :131-144

[6]

Merck, 2013, MERCK PROV UPD PHAS

[7]

Adenosine A2A receptor antagonist istradefylline reduces daily OFF time in Parkinson's disease [J].

Mizuno, Yoshikuni ;

Kondo, Tomoyoshi .

MOVEMENT DISORDERS, 2013, 28 (08) :1138-1141

[8]

LOW-DOSE L-DOPA THERAPY IN PARKINSONS-DISEASE - A 6-YEAR FOLLOW-UP-STUDY [J].

POEWE, WH ;

LEES, AJ ;

STERN, GM .

NEUROLOGY, 1986, 36 (11) :1528-1530

[9]

Istradefylline for Parkinson's disease patients experiencing motor fluctuations: Results of the KW-6002-US-018 study [J].

Pourcher, Emmanuelle ;

Fernandez, Hubert H. ;

Stacy, Mark ;

Mori, Akihisa ;

Ballerini, Rocco ;

Chaikin, Philip .

PARKINSONISM & RELATED DISORDERS, 2012, 18 (02) :178-184

[10]

Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial [J].

Rascol, O ;

Brooks, DJ ;

Melamed, E ;

Oertel, W ;

Poewe, W ;

Stocchi, F ;

Tolosa, E .

LANCET, 2005, 365 (9463) :947-954